Pfizer Yielding 8.7%? It Could Happen More Easily Than You Think
- Pfizer has a history of enormous buyback programs.
- However, these programs have been ineffective at reducing share count, as they simply soak up dilution.
- A better use of Pfizer's free cash flow is to pay it out in dividends.